Variable cartilage degradation in mice with diet-induced metabolic dysfunction: food for thought

Autor: Kozijn, A.E. ^{†, ‡, §}, Gierman, L.M. ^†, van der Ham, F. ^†, Mulder, P. ^†, Morrison, M.C. ^†, Kühnast, S. ^†, van der Heijden, R.A. ^‖, Stavro, P.M. ^¶, van Koppen, A. ^†, Pieterman, E.J. ^†, van den Hoek, A.M. ^†, Kleemann, R. ^†, Princen, H.M.G. ^†, Mastbergen, S.C. ^§, Lafeber, F.P.J.G. ^§, Zuurmond, A.-M. ^†, Bobeldijk, I. ^†, Weinans, H. ^{‡, §, #}, Stoop, R. ^†

Publikováno v: In Osteoarthritis and Cartilage January 2018 26(1):95-107

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Toll-Like Receptor-3 expression by maternal and fetal cells at the maternal-fetal interface is associated with development of preeclampsia

Autor: Gierman, L.M., Silva, G.B., Pervaiz, Z., Rakner, J., Mundal, S.B., Thaning, A.J., Elschot, M., Ostrop, J., Dahlberg, U., Thomsen, L.C.V., Bjørge, L., Iversen, A.C.

Publikováno v: In Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health October 2019 17 Supplement 1:S15-S15

Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice, a translational model for atherosclerosis

Autor: Gierman, L.M., Kühnast, S., Koudijs, A., Pieterman, E.J., Kloppenburg, M., Osch, G.J.V.M. van, Stojanovic-Susulic, V., Huizinga, T.W.J., Princen, H.M.G., Zuurmond. A.M.

Publikováno v: Annals of the Rheumatic Diseases, 5, 73, 921-927

Objective Hypercholesterolaemia, a risk factor for atherosclerosis (ATH), has been suggested to have a role in the development of osteoarthritis (OA). To test this hypothesis, the effect of cholesterol and different cholesterol-lowering treatments on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::fdce4e34139ef4959747f8edda7572dd
http://resolver.tudelft.nl/uuid:38012c33-28d8-40ac-a6e1-effe5bec01f9

Metabolic profiling reveals differences in concentrations of oxylipins and fatty acids secreted by the infrapatellar fat pad of donors with end-stage osteoarthritis and normal donors

Autor: Gierman, L.M., Wopereis, S., B. van el, Verheij, E.R., Werff-van der Vat, B.J.C., Bastiaansen-Jenniskens, Y.M., Osch, G.J.V.M. van, Kloppenburg, M., Stojanovic-Susulic, V., Huizinga, T.W.J., Zuurmond, A.M.

Publikováno v: Arthritis and Rheumatism, 10, 65, 2606-2614
Arthritis & Rheumatism, 65(10), 2606-2614. John Wiley & Sons Ltd.
Arthritis and Rheumatism, 65(10), 2606-2614

Objective The infrapatellar fat pad (IPFP) in the knee joint is hypothesized to contribute to osteoarthritis (OA) development by the IFPF possibly by influencing inflammatory processes. Oxylipins are essential mediators in the inflammatory process. W

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2746040a6cd1279589cb9fd9e68aebcf
http://resolver.tudelft.nl/uuid:d5bae4fd-e0d2-43d3-903d-54dd60b75e6d